RhumbLine Advisers’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $682K | Sell |
|
|||||
|
2025
Q1 | $574K | Buy |
|
|||||
|
2024
Q4 | $398K | Buy |
|
|||||
|
2024
Q3 | $970K | Sell |
|
|||||
|
2024
Q2 | $745K | Buy |
|
|||||
|
2024
Q1 | $657K | Sell |
|
|||||
|
2023
Q4 | $630K | Sell |
|
|||||
|
2023
Q3 | $542K | Sell |
|
|||||
|
2023
Q2 | $618K | Sell |
|
|||||
|
2023
Q1 | $728K | Buy |
|
|||||
|
2022
Q4 | $1.03M | Buy |
|
|||||
|
2022
Q3 | $832K | Buy |
|
|||||
|
2022
Q2 | $621K | Buy |
|
|||||
|
2022
Q1 | $636K | Sell |
|
|||||
|
2021
Q4 | $1.05M | Sell |
|
|||||
|
2021
Q3 | $831K | Buy |
|
|||||
|
2021
Q2 | $783K | Sell |
|
|||||
|
2021
Q1 | $796K | Sell |
|
|||||
|
2020
Q4 | $841K | Buy |
|
|||||
|
2020
Q3 | $529K | Sell |
|
|||||
|
2020
Q2 | $931K | Buy |
|
|||||
|
2020
Q1 | $479K | Buy |
|
|||||
|
2019
Q4 | $541K | Buy |
|
|||||
|
2019
Q3 | $1.16M | Buy |
|
|||||
|
2019
Q2 | $1.84M | Buy |
|
|||||
|
2019
Q1 | $2.05M | Sell |
|
|||||
|
2018
Q4 | $1.8M | Buy |
|
|||||
|
2018
Q3 | $1.71M | Sell |
|
|||||
|
2018
Q2 | $1.3M | Buy |
|
|||||
|
2018
Q1 | $1.78M | Buy |
|
|||||
|
2017
Q4 | $1.62M | Buy |
|
|||||
|
2017
Q3 | $366K | Buy |
|